Table 6 Analysis of T cell subsets, IgM, L%, NLR, CRP and D-Dimer in advanced stage (stage III & IV) NSCLC patients

CD3+ (%)

69.90(64.60，76.10)

63.20 (53.50，69.50)

< 0.001

CD4+ (%)

43.65 ± 10.30

36.52 ± 10.56

< 0.001

CD8+ (%)

21.71 (16.00，27.80)

20.10 (15.27，23.80)

0.031

CD4/CD8

1.99 (1.39，3.01)

1.79 (1.35，2.38)

0.222

CD16 + 56+ (%)

14.87 (10.30，22.70)

19.10 (13.30，29.40)

0.002

CD19+ (%)

9.10 (5.90，13.15)

9.00 (6.21，12.70)

0.596

IgM (g/L)

0.82 (0.58，1.29)

0.83 (0.55，1.03)

0.162

L%

16.10 (11.20，22.70)

12.40 (8.30，20.20)

0.027

NLR

4.65 (2.93，6.85)

5.88 (3.51，10.16)

0.028

CRP (mg/L)

22.82 (4.63，66.39)

31.59 (7.47，79.03)

0.177

D-Dimer (mg/L)

1.15 (0.59，2.77)

3.18 (1.05，5.42)

< 0.001